KARDIA-2: Add-On Zilebesiran Effectively Lowers Blood Pressure
A single subcutaneous dose of zilebesiran was associated with a reduction in mean ambulatory and office systolic blood pressure.
Read MoreInsights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.